Skip to main content
logo
QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
12.31
-0.26 (-2.07%)
At close: Oct 7, 2026, 4:00 PM EDT
12.10
-0.21 (-1.71%)
Pre-market: Oct 8, 2026, 6:41 AM EDT

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
North America Revenue
1.43B1.49B1.62B
EMEA Revenue
368.20M360.70M335.80M
China Revenue
307.60M334.70M325.00M
JPAC Revenue
-293.00M279.40M
Latin America Revenue
-252.90M222.90M
Other Geographies Revenue
570.60M545.90M502.30M
Revenue (Total)
2.67B2.73B2.78B

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Labs Revenue
1.50B1.51B1.43B
Immunohematology Revenue
555.50M543.80M522.00M
Donor Screening Revenue
38.30M52.60M115.10M
Transfusion Medicine Revenue
593.80M596.40M637.10M
Point of Care Revenue
558.70M601.60M694.60M
Molecular Diagnostics Revenue
22.70M26.50M24.00M
Revenue (Total)
2.67B2.73B2.78B

Adjusted EBITDA by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
North America Adjusted EBITDA
752.00M807.00M892.10M
EMEA Adjusted EBITDA
90.00M82.60M46.50M
China Adjusted EBITDA
120.20M141.20M130.50M
JPAC Adjusted EBITDA
-73.20M69.90M
Latin America Adjusted EBITDA
-78.40M63.60M
Other Geographies Adjusted EBITDA
154.40M151.60M133.50M
Corporate Adjusted EBITDA
-596.70M-585.40M-659.70M
Operating Income (Total)
-824.70M-919.20M-1.96B